PuraMed BioScience, Inc. Has Its Lead Product, LipiGesic®M Featured in Flaherty Financial News

PuraMed BioScience, Inc. PMBS is pleased to announce that its lead product, LipiGesic®M, for the acute treatment of migraines, has been featured in the December 20, 2011 issue of Flaherty Financial News Newsletter published by Flaherty Financial News Inc. The report can be found at http://tinyurl.com/cf5mc6w. "We are very excited to be featured in the Flaherty Financial News Newsletter," said PuraMed CEO, Russ Mitchell. "This publication has online distribution to over 10 million investors and we think this is a great step in getting the word out about our product, LipiGesic®M."